Abstract
Naturally occurring positively charged proteins can be promising carriers for nucleic acid transport in gene therapy. The most attractive alternative among them is histones. In this work, we describe expression and purification of recombinant human histones H2A and H2B and of chimeric histone H2A with HIV-1 TAT fragment (TAT-peptide). The proposed method of purification of histone proteins can significantly reduce the content of bacterial endotoxins in the target preparation, which makes it possible to use these proteins in in vivo experiments. The transfection ability of plasmid DNA complexes with core histones H2A and H2B and the chimeric histone was demonstrated. A highly specific and efficient transfection of human HT1080 cell line with the use of histones H2A and H2B was detected, whereas transfection by plasmid DNA complexes with chimeric H2A-TAT protein was observed for many cell lines.
Similar content being viewed by others
REFERENCES
Bakhtiar, A., Sayyad, M., Rosli, R., Maruyama, A., and Chowdhury, E.H., Intracellular delivery of potential therapeutic genes: prospects in cancer gene therapy, Curr. Gene Ther., 2014, vol. 14, pp. 247–257.
Nayerossadat, N., Maedeh, T., and Ali, P.A., Viral and non-viral delivery systems for gene delivery, Adv. Biomed. Res., 2012, vol. 1, p. 27.
Berry, G.E. and Asokan, A., Cellular transduction mechanisms of adeno-associated viral vectors, Curr. Opin. Virol., 2016, vol. 21, pp. 54–60.
Ibraheem, D., Elaissari, A., and Fessi, H., Gene therapy and DNA delivery systems, Int. J. Pharm., 2014, vol. 459, pp. 70–83.
Lukashev, A.N. and Zamyatnin, A.A., Jr., Viral vectors for gene therapy: Current state and clinical perspectives, Biochemistry (Moscow), 2016, vol. 81, pp. 700–708.
Ramamoorth, M. and Narvekar, A., Non-viral vectors in gene therapy–an overview, J. Clin. Diagn. Res., 2015, vol. 9, pp. GE01–GE06.
Slivac, I., Guay, D., Mangion, M., Champeil, J., and Gaillet, B., Non-viral nucleic acid delivery methods, Expert Opin. Biol. Ther., 2017, vol. 17, pp. 105–118.
Zhang, C., Jin, R., Zhao, P., and Lin, C., A family of cationic polyamides for in vitro and in vivo gene transfection, Acta Biomater., 2015, vol. 22, pp. 120–130.
Zhang, P. and Wagner, E., History of polymeric gene delivery systems, Top. Curr. Chem. (Cham), 2017, vol. 375, p. 26.
Stanzl, E.G., Trantow, B.M., Vargas, J.R., and Wender, P.A., Fifteen years of cell-penetrating, guanidinium-rich molecular transporters: basic science, research tools, and clinical applications, Acc. Chem. Res., 2013, vol. 46, pp. 2944–2954.
Kouchakzadeh, H. and Abbas Shojaosadati, S., The prominent role of protein-based delivery systems on the development of cancer treatment, Curr. Pharm. Des., 2016, vol. 22, pp. 3455–3465.
Komin, A., Russell, L.M., Hristova, K.A., and Searson, P.C., Peptide-based strategies for enhanced cell uptake, transcellular transport, and circulation: Mechanisms and challenges, Adv. Drug Delivery Rev., 2017, vols. 110–111, pp. 52–64.
Radis-Baptista, G., Campelo, I.S., Morlighem, J.R.L., et al., Cell-penetrating peptides (CPPs): From delivery of nucleic acids and antigens to transduction of engineered nucleases for application in transgenesis, J. Biotechnol., 2017, vol. 252, pp. 15–26.
Balicki, D. and Beutler, E., Histone H2A significantly enhances in vitro DNA transfection, Mol. Med., 1997, vol. 3, pp. 782–787.
Puebla, I., Esseghir, S., Mortlock, A., et al., A recombinant H1 histone-based system for efficient delivery of nucleic acids, J. Biotechnol., 2003, vol. 105, pp. 215–226.
Kaouass, M., Beaulieu, R., and Balicki, D., Histonefection: Novel and potent non-viral gene delivery, J. Controlled Release, 2006, vol. 113, pp. 245–254.
Reilly, M.J., Larsen, J.D., and Sullivan, M.O., Histone H3 tail peptides and poly(ethylenimine) have synergistic effects for gene delivery, Mol. Pharm., 2012, vol. 9, pp. 1031–1040.
Hariton-Gazal, E., Rosenbluh, J., Graessmann, A., et al., Direct translocation of histone molecules across cell membranes, J. Cell Sci., 2003, vol. 116, pp. 4577–4586.
Wagstaff, K.M., Glover, D.J., Tremethick, D.J., and Jans, D.A., Histone-mediated transduction as an efficient means for gene delivery, Mol. Ther., 2007, vol. 15, pp. 721–731.
Schneeweiss, A., Buyens, K., Giese, M., et al., Synergistic effects between natural histone mixtures and polyethylenimine in non-viral gene delivery in vitro, Int. J. Pharm., 2010, vol. 400, pp. 86–95.
Torchilin, V.P., Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers, Adv. Drug Delivery Rev., 2008, vol. 60, pp. 548–558.
Sawant, R. and Torchilin, V., Intracellular transduction using cell-penetrating peptides, Mol. Biosyst., 2011, vol. 6, pp. 628–640.
Ulasov, A.V., Khramtsov, Y.V., Trusov, G.A., et al., Properties of PEI-based polyplex nanoparticles that correlate with their transfection efficacy, Mol. Ther., 2011, vol. 19, pp. 103–112.
Johns, E.W., The isolation and purification of histones, Methods Cell Biol., 1977, vol. 16, pp. 183–203.
von Holt, C., Brandt, W.F., Greyling, H.J., et al., Isolation and characterization of histones, Methods Enzymol., 1989, vol. 170, pp. 431–523.
Tanaka, Y., Tawaramoto-Sasanuma, M., Kawaguchi, S., et al., Expression and purification of recombinant human histones, Methods, 2004, vol. 33, pp. 3–11.
Shechter, D., Dormann, H.L., Allis, C.D., and Hake, S.B., Extraction, purification and analysis of histones, Nat. Protoc., 2007, vol. 2, pp. 1445–1457.
Gusarov, D.A., Methods for bacterial endotoxines removal from protein solutions, Biopharm. J., 2009, vol. 1, no. 3, pp. 10–17.
Gusarov, D., Sokolova, I., Vorobjeva, T., and Brykova, N., Positively charged proteins: Separation and depyrogenation by means of HPLC (by the example of recombinant histone H1.3 variant), Biopharm. J., 2011, vol. 3, pp. 16–23.
Klinker, H., Haas, C., Harrer, N., Becker, P.B., and Mueller-Planitz, F., Rapid purification of recombinant histones, PLoS One, 2014, vol. 9, p. e104029.
Fujitani, H. and Holoubek, V., Recovery of histones by acid extraction from chromatin and from artificial DNA-histone complex, Tex. Rep. Biol. Med., 1974, vol. 32, pp. 461–478.
Kawashige, M., Sendo, T., Otsubo, K., et al., Quality evaluation of commercial lyophilized human growth hormone preparations, Biol. Pharm. Bull., 1995, vol. 18, pp. 1793–1796.
Ahangari, G., Ostadali, M.R., Rabani, A., et al., Growth hormone antibodies formation in patients treated with recombinant human growth hormone, Int. J. Immunopathol. Pharmacol., 2004, vol. 17, pp. 33–38.
Balicki, D., Reisfeld, R.A., Pertl, U., et al., Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma, Proc. Natl. Acad. Sci. U. S. A., 2000, vol. 97, pp. 11 500–11 504.
Torchilin, V.P., Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery, Biopolymers, 2008, vol. 90, pp. 604–610.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated by I. N. Shipounova
About this article
Cite this article
Zinovyeva, M.V., Sass, A.V., Vvedensky, A.V. et al. Recombinant Histones as an Instrument for the Delivery of Nucleic Acids into Eukaryotic Cells. Mol. Genet. Microbiol. Virol. 33, 187–194 (2018). https://doi.org/10.3103/S0891416818030072
Received:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0891416818030072